PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The existing situation has exposed some structural weaknesses during the EU’s medicines provide chain plus a high dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides reported. She proposed that provide chain problems be resolved within an EU pharmaceutical system envisioned to generally be introduc